Opigolix
CAS号 | 912587-25-8 | 货号 | BCP36620 |
中文名 | Opigolix | ||
英文名 | Opigolix | ||
中文别名 | |||
英文别名 | ASP1707; ASP-1707; ASP 1707; | ||
分子式 | C25H19F3N4O5S | 分子量 | 544.5 |
生物活性 | Opigolix, also known as ASP1707, is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which was under development by Astellas Pharma for the treatment of endometriosis and rheumatoid arthritis. It was also under investigation for the treatment of prostate cancer. It reached phase II clinical trials for both endometriosis and rheumatoid arthritis prior to the discontinuation of its development in April 2018. | ||
信号通路 | GPCR/G Protein | ||
靶 点 | GnRH Receptor |
结构式

本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服:
- 全国免费电话:400-099-8200
瀚香生物(Biochempartner) 的所有产品和服务仅用于科学研究,禁止用于人体和治疗!